Adaptive Biotechnologies (ADPT) Misses Q3 EPS by 1c
Tweet
Share
E-mailGet Alerts ADPT Hot Sheet
Price: $28.06 --0%
Revenue Growth %: -23.8%
Financial Fact:
Net income (loss) (in Dollars per share): -5.69
Today's EPS Names:
OCCI, ALZN, ASPU, More
Revenue Growth %: -23.8%
Financial Fact:
Net income (loss) (in Dollars per share): -5.69
Today's EPS Names:
OCCI, ALZN, ASPU, More
Join SI Premium – FREE
Adaptive Biotechnologies (NASDAQ: ADPT) reported Q3 EPS of ($0.35), $0.01 worse than the analyst estimate of ($0.34). Revenue for the quarter came in at $37.92 million versus the consensus estimate of $42.96 million.
For earnings history and earnings-related data on Adaptive Biotechnologies (ADPT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Adeptus Biotechnologies Corp. (ADPT) PT Raised to $34 at BTIG
- AutoZone (AZO) Tops Q4 EPS by $1.76, Misses on Revenue
- Societe Generale SA (GLE:FP) (SCGLY) PT Raised to EUR83 at JPMorgan
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
